UBS Group Portfolio holdings
UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$422M |
| 2 |
iShares US Treasury Bond ETF
GOVT
|
+$342M |
| 3 |
Mondelez International
MDLZ
|
+$328M |
| 4 |
SHPG
Shire pic
SHPG
|
+$323M |
| 5 |
iShares 5-10 Year Investment Grade Corporate Bond ETF
IGIB
|
+$258M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
MON
Monsanto Co
MON
|
+$658M |
| 2 |
COL
Rockwell Collins
COL
|
+$266M |
| 3 |
JWN
Nordstrom
JWN
|
+$264M |
| 4 |
Deutsche Bank
DB
|
+$258M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$250M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 7.19% |
| 2 | Technology | 6.4% |
| 3 | Healthcare | 6.06% |
| 4 | Industrials | 4.94% |
| 5 | Consumer Discretionary | 4.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AET
2526
CALL
DELISTED
Aetna Inc
AET
| $3.58M | ﹤0.01% |
+22,500
| New | +$3.51M |
|
2527
Outfront Media
OUT
$5.61B
| $3.58M | ﹤0.01% |
144,296
+13,718
| +11% | +$302K |
|
|
BEAT
2528
DELISTED
BioTelemetry, Inc.
BEAT
| $3.56M | ﹤0.01% |
107,945
+23,677
| +28% | +$820K |
|
2529
PUT
Salesforce
CRM
$151B
| $3.56M | ﹤0.01% |
38,100
+21,500
| +130% | +$1.98M |
|
|
GARS
2530
DELISTED
Garrison Capital Inc.
GARS
| $3.56M | ﹤0.01% |
422,223
-945
| -0.2% | -$7.82K |
|
|
AGGP
2531
DELISTED
IQ Enhanced Core Plus Bond U.S. ETF
AGGP
| $3.55M | ﹤0.01% |
176,913
+89,292
| +102% | +$1.79M |
|
|
VISN
2532
Vistance Networks Inc
VISN
$2.65B
| $3.54M | ﹤0.01% |
106,758
-136,240
| -56% | -$4.65M |
|
|
BLE
2533
DELISTED
BlackRock Municipal Income Trust II
BLE
| $3.54M | ﹤0.01% |
232,924
-24,089
| -9% | -$373K |
|
2534
Warner Bros
WBD
$65.9B
| $3.54M | ﹤0.01% |
166,244
+20,787
| +14% | +$490K |
|
|
DRNA
2535
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $3.54M | ﹤0.01% |
615,017
+331,084
| +117% | +$1.2M |
|
2536
Horizon Technology Finance
HRZN
$295M
| $3.53M | ﹤0.01% |
318,054
-37,298
| -10% | -$407K |
|
2537
PUT
iShares US Real Estate ETF
IYR
$4.66B
| $3.52M | ﹤0.01% |
+44,100
| New | +$3.54M |
|
|
MYOK
2538
DELISTED
MyoKardia, Inc. Common Stock
MYOK
| $3.52M | ﹤0.01% |
+82,121
| New | +$2.62M |
|
|
WDR
2539
DELISTED
Waddell & Reed Financial, Inc.
WDR
| $3.51M | ﹤0.01% |
174,745
+17,683
| +11% | +$340K |
|
|
FRBK
2540
DELISTED
Republic First Bancorp Inc
FRBK
| $3.5M | ﹤0.01% |
378,912
+3,857
| +1% | +$34.4K |
|
|
AWP
2541
abrdn Global Premier Properties Fund
AWP
$372M
| $3.49M | ﹤0.01% |
175,426
-52,051
| -23% | -$1.01M |
|
2542
InterDigital
IDCC
$7.87B
| $3.49M | ﹤0.01% |
47,311
-19,232
| -29% | -$1.41M |
|
2543
First American
FAF
$7.66B
| $3.48M | ﹤0.01% |
69,669
+18,864
| +37% | +$901K |
|
|
WPX
2544
DELISTED
WPX Energy, Inc.
WPX
| $3.48M | ﹤0.01% |
302,203
+89,811
| +42% | +$919K |
|
2545
CALL
LyondellBasell Industries
LYB
$20B
| $3.47M | ﹤0.01% |
35,000
| – | – |
|
2546
Autoliv
ALV
$9.02B
| $3.46M | ﹤0.01% |
38,917
+16,108
| +71% | +$1.31M |
|
|
NDP
2547
DELISTED
TORTOISE ENERGY INDEPENDENCE FUND, INC.
NDP
| $3.46M | ﹤0.01% |
32,365
+4,406
| +16% | +$466K |
|
2548
Norwegian Cruise Line
NCLH
$8.51B
| $3.44M | ﹤0.01% |
63,636
+16,202
| +34% | +$906K |
|
2549
ProShares Short Russell2000
RWM
$132M
| $3.44M | ﹤0.01% |
78,704
-1,649
| -2% | -$76.2K |
|
2550
Integra LifeSciences
IART
$1.29B
| $3.44M | ﹤0.01% |
68,096
+9,503
| +16% | +$488K |
|
Similar funds
UBS Group's Q3 2017 Portfolio in Review
As of Q3 2017, UBS Group held 8,493 positions worth $216B, up 12% from $193B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
UBS Group deployed $15.2B of net new capital in Q3 2017, opening 749 new positions and adding to 3,978 existing holdings. Its largest new stake was Baker Hughes: 613,477 shares worth $22.5M.
By sector, the portfolio is most concentrated in Financials at 7.2% of assets, down from 7.7% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Monsanto Co, an estimated $658M trimmed.
- UBS Group's largest Q3 2017 buy was Baker Hughes: 613,477 shares worth $22.5M.
- UBS Group added most to State Street SPDR S&P 500 ETF Trust in Q3 2017, an estimated $422M increase.
- UBS Group's biggest Q3 2017 reduction was Monsanto Co, cutting an estimated $658M.
- UBS Group fully exited Oneok Partners LP in Q3 2017, selling an estimated $218M.
- UBS Group's ten largest holdings make up 16% of its $216B portfolio in Q3 2017.
- UBS Group opened 749 new positions and closed 707 in Q3 2017.
- UBS Group's portfolio value rose 12% quarter-over-quarter to $216B.
Based on UBS Group's 13F filing for Q3 2017, filed 14 Nov 2017.